"Dried Blood Spot Testing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Techniques for using whole blood samples collected on filter paper for a variety of clinical laboratory tests.
| Descriptor ID |
D059788
|
| MeSH Number(s) |
E01.370.225.124.100.232 E05.200.124.100.232
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dried Blood Spot Testing".
Below are MeSH descriptors whose meaning is more specific than "Dried Blood Spot Testing".
This graph shows the total number of publications written about "Dried Blood Spot Testing" by people in this website by year, and whether "Dried Blood Spot Testing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 1 | 2 |
| 2016 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 2 | 2 | 4 |
| 2022 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dried Blood Spot Testing" by people in Profiles.
-
Development and validation of an LC-MS/MS multiplex assay for the quantification of bedaquiline, n-desmethyl bedaquiline, linezolid, levofloxacin, and clofazimine in dried blood spots. J Chromatogr B Analyt Technol Biomed Life Sci. 2025 Feb 01; 1252:124470.
-
Performance of patient-collected dried blood specimens for HIV-1 viral load testing in South Africa. AIDS. 2024 Dec 01; 38(15):2050-2055.
-
The performance of using dried blood spot specimens for HIV-1 viral load testing: A systematic review and meta-analysis. PLoS Med. 2022 08; 19(8):e1004076.
-
Correlation of dried blood spots and plasma for quantification of Immunoglobulin (IgG) against Receptor binding domain and full length spike protein of SARS-CoV-2. J Virol Methods. 2022 02; 300:114394.
-
Early Diagnosis of HIV-1 and HIV-2 Using Cobas HIV-1/HIV-2 Qualitative Test: A Novel Qualitative Nucleic Acid Amplification Test for Plasma, Serum, and Dried Blood Spot Specimens. J Acquir Immune Defic Syndr. 2021 08 15; 87(5):1187-1195.
-
PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial. PLoS Med. 2021 06; 18(6):e1003670.
-
Classification of HIV-1 virological treatment failure using the Roche cobas plasma separation card on cobas 8800 compared to dried blood spots on Abbott RealTime HIV-1. J Clin Virol. 2021 07; 140:104839.
-
Comparison of Alere q whole blood viral load with DBS and plasma viral load in the classification of HIV virological failure. PLoS One. 2020; 15(5):e0232345.
-
The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study. BMC Infect Dis. 2020 Mar 26; 20(1):248.
-
Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13. BMC Infect Dis. 2019 Sep 16; 19(Suppl 1):787.